Our study gives you answers and trends, saving you time and aiding your decisions.You can have this report todayOur new report can benefit everybody interested in pharmaceutical manufacturing. We forecast commercial potential, discovering trends. Do you want to harness those opportunities? Please let us know how we can help. You can stay ahead by ordering our report now.
Table of Contents 1. Executive Summary
1.1 Contract Pharma Manufacturing 2010-2025
1.2 Aims, Scope and Format of the Report
1.3 Research & Analysis Methods
2. Introduction to Pharma Outsourcing of Manufacturing
2.1 Contract Pharma Described
2.1.1 Evolving Nature of Contract Research Organisations (CROs) and Contract Manufacturing Organisations (CMOs)
2.2 Contract Development and Manufacturing Organisations (CDMO)
2.3 Why Are Pharma Companies Interested in Contract Pharma?
2.3.1 Small/Mid-sized Pharma and Biotech Have a Flexible Attitude to Outsourcing
2.3.2 Lack of Capacity is Still a Major Reason to Outsource
2.3.3 Tactical vs. Strategic Use of Outsourcing
2.4 The Changing Nature of the Pharmaceutical Market is Affecting the CRM Market
2.4.1 The Rise of Generics
2.4.2 Pipelines are Becoming Expensive
2.4.3 The Decline of the Traditional Blockbuster
2.5 Biopharmaceutical Drug Discovery and Development by Contract Pharma Companies will Continue to Increase
2.6 Disadvantages of Outsourcing in the Pharmaceutical Industry Can be Overcome
3. Regulatory Aspects of Pharma Outsourcing for Manufacturing
3.1 Legal Liabilities and R
Copyright©2010 PR Newswire.
All rights reserved